Abstract:Background Edge‐to‐edge transcatheter mitral valve repair as salvage therapy in high surgical risk patients with severe mitral regurgitation presenting with cardiogenic shock (CS) has been described in small case series, but large clinical results have not been reported. This study aimed to evaluate outcomes of transcatheter mitral valve repair with MitraClip in patients with mitral regurgitation and CS using a large national database. Methods and Results From January 2014 to March 2019, we identified hospitalizations for CS in patients with mitral valve disease using data from Centers for Medicare and Medicaid Services. Those with a prior surgical or percutaneous mitral valve intervention were excluded. We compared survival between patients who underwent MitraClip during the index hospitalization and those who did not using propensity‐matched analysis. The analysis included 38 166 patients (mean age, 71±11 years, 41.6% women) of whom 622 (1.6%) underwent MitraClip. MitraClip was increasingly used during CS hospitalizations over the study period ( P <0.001). After matching, patients receiving MitraClip had significantly lower in‐hospital mortality (odds ratio, 0.6; 95% CI, 0.47–0.77; P <0.001) and 1‐year mortality (hazard ratio, 0.76; 95% CI, 0.65–0.88; P <0.001) compared with those without MitraClip. The survival benefit associated with MitraClip was consistent across subgroups of interest, with the exception of patients requiring acute mechanical circulatory support or hemodialysis at index. Conclusions In patients with mitral regurgitation presenting with CS, use of MitraClip is increasing and associated with greater in‐hospital and 1‐year survival. Further studies are warranted to optimize patient selection and procedure timing for those receiving MitraClip as a treatment option in CS. Nonstandard Abbreviations and Acronyms CCS Clinical Classification Software CS cardiogenic shock MCS mechanical circulatory support MR mitral regurgitation TMVr transcatheter mitral valve repair Clinical Perspective What Is New? This study reports clinical outcomes for a large nationwide cohort of patients who underwent transcatheter mitral valve repair with MitraClip in the setting of cardiogenic shock. Over the study period from 2014 through early 2019, the use of transcatheter mitral valve repair during cardiogenic shock hospitalizations increased significantly. In a matched‐cohort analysis of 1192 patients, MitraClip therapy was associated with higher in‐hospital and 1‐year survival in patients with mitral regurgitation and cardiogenic shock. What Are the Clinical Implications? MitraClip may be considered as a therapeutic option for some critically ill patients. Clinical studies on the patient and procedural characteristics associated with MitraClip in the setting of cardiogenic shock could further improve outcomes by optimizing procedural timing and patient selection. Management of severe mitral regurgitation (MR) in patients presenting with cardiogenic shock (CS) remains challenging because of complications including respiratory failure from acute pulmonary edema and multiorgan dysfunction. 1 , 2 Inotropic and mechanical circulatory support may be lifesaving, but MR and shock may persist without definitive treatment. Surgical mitral valve repair or replacement in these critically ill patients carries significant mortality and morbidities. 3 The typical pathology of severe MR in CS consists of either a flail leaflet segment secondary to ruptured chordae or papillary muscle because of acute myocardial infarction, or progressive decompensation with chronic MR from leaflet restriction because of ischemic or non‐ischemic cardiomyopathy. Given the high surgical risk in this patient population, edge‐to‐edge transcatheter mitral valve repair (TMVr) has been attempted as salvage therap -Abstract Truncated-

800.58 Mitral Transcatheter Edge-to-Edge Repair In-Hospital Outcomes and Mitral Valve Surgery Readmission Trends: National Readmission Database 2018-2020

Outcomes of mitral transcatheter edge to edge repair with MitraClip™ - An Indian single center experience

Investigation of outcomes following transcatheter edge to edge repair of the mitral valve versus medical management alone in patients with cardiogenic shock and mitral regurgitation

Preliminary Evaluation of Transesophageal Echocardiography in Percutaneous Edge-to-edge Repair of Mitral Regurgitation

Transcatheter Mitral Valve Repair Using the Edge-to-Edge Clip

Percutaneous mitral valve repair with the MitraClip: early results from the MitraClip Asia-Pacific Registry (MARS).

Surgery and Transcatheter Intervention for Degenerative Mitral Regurgitation in The United States

The MitraClip Asia-Pacific Registry: Differences in Outcomes Between Functional and Degenerative Mitral Regurgitation.

A review regarding the article 'Clinical and Echocardiographic Outcomes of Patients Undergoing Transcatheter Edge-to-Edge Repair for Functional vs Degenerative Mitral Valve Regurgitation.'

Transcatheter mitral valve implantation using TENDYNE valve for the treatment of residual severe mitral regurgitation post-transcatheter mitral valve edge-to-edge repair: a case report

Transcatheter Edge-to-Edge Repair in Valvular Heart Disease: A Comprehensive Exploration of Equipment, Efficacy, Gender, Racial, and Socioeconomic Disparities, and Future Prospects

Mitral Valve Surgery After Transcatheter Edge-to-Edge Repair: Mid-Term Outcomes From the CUTTING-EDGE International Registry

Percutaneous Transcatheter Edge-to-Edge Mitral Valve Repair With MitraClip System in the Era of G4

Outcomes After Transcatheter Edge-to-Edge Mitral Valve Repair According to Mitral Regurgitation Etiology and Cardiac Remodeling

Risk factors for early mortality following transcatheter edge-to-edge repair of mitral regurgitation

Evolving indications for transcatheter mitral edge-to-edge repair

Survival Following Edge-to-Edge Transcatheter Mitral Valve Repair in Patients With Cardiogenic Shock: A Nationwide Analysis.

Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2

Impact of Mitral Regurgitation Etiology on Mitral Surgery After Transcatheter Edge-to-Edge Repair

Clinical Outcomes and Cost Analysis in Patients with Heart Failure Undergoing Transcatheter Edge-to-Edge Repair for Mitral Valve Regurgitation

Transcatheter mitral valve repair with MitraClip: comparison of NT, NTr, and XTr Devices